Table 3.
Metabolite ratios of MHE and control subjects.
| Metabolite ratios | MHE | Controls | P values | |||
|---|---|---|---|---|---|---|
| Frontal (Mean ± SD) [A] | Occipital (Mean ± SD) [B] | Frontal (Mean ± SD) [C] | Occipital (Mean ± SD) [D] | [A] vs [C] | [B] vs [D] | |
| Ch_d/Cr_d | 0.786 ± 0.142 | 0.697 ± 0.168 | 1.001 ± 0.082 | 0.954 ± 0.092 | 0.002 | 0.002 |
| NAA_d/Cr_d | 1.612 ± 0.119 | 1.445 ± 0.141 | 1.716 ± 0.157 | 1.624 ± 0.100 | 0.152 | 0.009 |
| mICh/Cr_d | 0.064 ± 0.019 | 0.058 ± 0.024 | 0.112 ± 0.011 | 0.117 ± 0.022 | 0.000 | 0.000 |
| Asp/Cr_d | 0.023 ± 0.007 | 0.028 ± 0.006 | 0.025 ± 0.004 | 0.025 ± 0.005 | 0.603 | 0.294 |
| Cr/Cr_d | 0.012 ± 0.006 | 0.017 ± 0.006 | 0.014 ± 0.002 | 0.014 ± 0.004 | 0.360 | 0.289 |
| Glx/Cr_d | 0.148 ± 0.034 | 0.178 ± 0.062 | 0.120 ± 0.016 | 0.116 ± 0.014 | 0.029 | 0.011 |
| mI/Cr_d | 0.011 ± 0.005 | 0.013 ± 0.005 | 0.022 ± 0.004 | 0.020 ± 0.005 | 0.000 | 0.017 |
| NAA/Cr_d | 0.308 ± 0.081 | 0.271 ± 0.076 | 0.321 ± 0.028 | 0.304 ± 0.052 | 0.653 | 0.314 |
| Tau/Cr_d | 0.007 ± 0.002 | 0.007 ± 0.003 | 0.011 ± 0.002 | 0.009 ± 0.003 | 0.016 | 0.347 |
| PCh/Cr_d | 0.007 ± 0.003 | 0.008 ± 0.003 | 0.007 ± 0.002 | 0.007 ± 0.002 | 0.817 | 0.639 |
| GABA/Cr_d | 0.007 ± 0.002 | 0.007 ± 0.004 | 0.006 ± 0.003 | 0.007 ± 0.003 | 0.757 | 0.829 |
| PE/Cr_d | 0.005 ± 0.002 | 0.005 ± 0.003 | 0.007 ± 0.002 | 0.005 ± 0.001 | 0.095 | 0.638 |
| ThrLac/Cr_d | 0.012 ± 0.005 | 0.011 ± 0.003 | 0.011 ± 0.002 | 0.015 ± 0.009 | 0.456 | 0.259 |
Cr_d, diagonal creatine; Ch_d, diagonal choline; NAA_d, diagonal N-acetyl aspartate; mICh, overlapping cross peak of myo-inositol and choline; Asp, aspartate; Glx, glutamate/glutamine; mI, myo-inositol; Tau, taurine; PCh, phosphocholine; GABA, gamma-aminobutyric acid; PE, phosphoethanolamine; ThrLac, overlapping cross peaks of threonine and lactate.